Literature DB >> 31634480

A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics.

Terence L Kirley1, Andrew B Norman2, Hanna N Wetzel2.   

Abstract

An anti-cocaine monoclonal antibody (mAb) designated h2E2 will soon enter clinical trials for the treatment of cocaine abuse disorders. Importantly, this antibody selectively binds cocaine and its active metabolite, cocaethylene, with high affinity, while binding inactive metabolites with substantially lower affinities. Here, we used differential scanning fluorimetry (DSF) to characterize the stability and ligand binding properties of this antibody and its cocaine-binding Fab fragment. The Sypro orange dye commonly used for DSF revealed multiple overlapping thermal protein denaturation transitions for both the mAb and the Fab fragment, making quantitative analysis of ligand binding by thermal stabilization problematic. However, by using the "rotor" dye, DASPMI (4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide), which measures the rotational restriction of the fluorescent dye (as opposed to the Sypro orange dye which measures the hydrophobicity of the dye microenvironment), a simple two state thermal denaturation transition that is stabilized by ligand binding was observed for the h2E2 mAb, enabling Boltzmann fitting and quantitative thermodynamic analysis of the DASPMI DSF mAb cocaine and metabolite binding data. The computed affinities were consistent with ligand binding affinities determined using other techniques. Thus, this novel DASPMI DSF method can simply, inexpensively, and very rapidly generate ligand binding constants for the h2E2 mAb, despite the presence of multiple, overlapping, thermally unfolding protein domains characteristic of all mAbs. This approach is likely applicable to other mAbs currently in use for many research and therapeutic applications.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DASPMI rotor dye; Differential scanning fluorimetry; Ligand binding; Monoclonal antibody; Protein denaturation; Thermodynamics

Year:  2019        PMID: 31634480      PMCID: PMC6939126          DOI: 10.1016/j.jim.2019.112676

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis.

Authors:  Stefan Paula; Michael R Tabet; Susan M Keenan; William J Welsh; W James Ball
Journal:  J Mol Biol       Date:  2003-01-17       Impact factor: 5.469

2.  A Recombinant Humanized Anticocaine Monoclonal Antibody Alters the Urinary Clearance of Cocaine and Its Metabolites in Rats.

Authors:  Jordan A Marckel; Hanna N Wetzel; Sihame Amlal; Hassane Amlal; Andrew B Norman
Journal:  Drug Metab Dispos       Date:  2018-12-21       Impact factor: 3.922

3.  High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody.

Authors:  Anita Niedziela-Majka; Elaine Kan; Perry Weissburg; Upasana Mehra; Scott Sellers; Roman Sakowicz
Journal:  J Biomol Screen       Date:  2014-11-10

4.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate.

Authors:  Hanna N Wetzel; Rose P Webster; Fatima O Saeed; Terence L Kirley; William J Ball; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2017-04-23       Impact factor: 3.575

Review 5.  Differential scanning calorimetry as a tool for protein folding and stability.

Authors:  Christopher M Johnson
Journal:  Arch Biochem Biophys       Date:  2012-09-27       Impact factor: 4.013

6.  Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Authors:  Thomas R Kosten; Coreen B Domingo; Daryl Shorter; Frank Orson; Charles Green; Eugene Somoza; Rachelle Sekerka; Frances R Levin; John J Mariani; Maxine Stitzer; D Andrew Tompkins; John Rotrosen; Vatsal Thakkar; Benjamin Smoak; Kyle Kampman
Journal:  Drug Alcohol Depend       Date:  2014-04-16       Impact factor: 4.492

7.  Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2016-06-21       Impact factor: 3.575

8.  Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.

Authors:  Stefan Paula; Michael R Tabet; Carol D Farr; Andrew B Norman; W James Ball
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

9.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

10.  Probing cocaine-antibody interactions in buffer and human serum.

Authors:  Muthu Ramakrishnan; Fernando Alves De Melo; Berma M Kinsey; John E Ladbury; Thomas R Kosten; Frank M Orson
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

View more
  6 in total

1.  Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2020-09-26       Impact factor: 3.575

2.  Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2022-05-14

3.  Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.

Authors:  Kari Kopra; Salla Valtonen; Randa Mahran; Jonas N Kapp; Nazia Hassan; William Gillette; Bryce Dennis; Lianbo Li; Kenneth D Westover; Andreas Plückthun; Harri Härmä
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

4.  Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2020-12-18       Impact factor: 3.575

5.  Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2022-09-24

6.  Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  J Immunol Methods       Date:  2021-07-21       Impact factor: 2.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.